spanky2026
GLP-1 Enthusiast
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
Article implies some well-connected senior citizen got a compassionate use exception for Reta before it is approved? Anyone know more about this? Interesting.